Robert Rintoul, PhD, FRCP, University of Cambridge and Royal Papworth Hospital NHS Foundation Trust, Cambridge; Chair of the UK Lung Cancer Coalition Clinical Advisory Group discusses the report released by the UKLCC in November 2021 about strategies to increase 5 year survival for patients with lung cancer in the UK to 25% by 2025. The COVID-19 pandemic has caused a large shift backwards in 5 year survival for patients with lung cancer, so this report outlines the urgent need for improvements in this area.